Literature DB >> 14584906

TRACP as an osteopontin phosphatase.

Göran Andersson1, Barbro Ek-Rylander, Karin Hollberg, Jenny Ljusberg-Sjölander, Pernilla Lång, Maria Norgård, Yunling Wang, Shi-Jin Zhang.   

Abstract

TRACP is synthesized as a latent proenzyme requiring proteolytic processing to attain maximal phosphatase activity. Excision of an exposed loop domain abolishes the interaction between the loop residue Asp146 and a ligand to the redox-sensitive iron of the active site, most likely Asn91, providing a mechanism for the enzyme repression. Both cathepsin K and L efficiently cleave in the loop domain and activate the latent enzyme, and we propose that cathepsin K acts as a physiological activator of TRACP in osteoclasts, whereas cathepsin L might fulfill a similar role in different types of macrophages. Considering the rather broad substrate specificity of TRACP, a tight regulation of its activity in the cell appears warranted. Besides proteolytic cleavage, the enzyme should need a specific local environment with a slightly acidic pH and reducing equivalents to keep the enzyme fully active. Cellular subcompartments where these required conditions prevail are potential subcellular site(s) of TRACP action. Of bone phosphoproteins shown to be substrates for TRACP, both osteopontin and bone sialoprotein are colocalized with TRACP in the resorption lacuna of the osteoclasts, and dephosphorylation of OPN impair its ability to promote adhesion as well as migration of osteoclasts in vitro. A role for TRACP as an osteopontin phosphatase in bone is therefore suggested. The expression of TRACP as well as OPN in other tissues with possible interactions between the two could suggest a more general function for TRACP as a regulator of OPN phosphorylation and bioactivity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14584906     DOI: 10.1359/jbmr.2003.18.10.1912

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  23 in total

1.  The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells.

Authors:  Lauren A Thurgood; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2011-09-20

2.  Assay of in vitro osteoclast activity on dentine, and synthetic calcium phosphate bone substitutes.

Authors:  Zahi Badran; Paul Pilet; Elise Verron; Jean-Michel Bouler; Pierre Weiss; Gaël Grimandi; Jérôme Guicheux; Assem Soueidan
Journal:  J Mater Sci Mater Med       Date:  2011-12-22       Impact factor: 3.896

3.  Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix-resorbing clasts.

Authors:  Karin Hollberg; Joakim Nordahl; Kjell Hultenby; Silwa Mengarelli-Widholm; Göran Andersson; Finn P Reinholt
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

4.  Direct observation of multiple protonation states in recombinant human purple acid phosphatase.

Authors:  Enrico G Funhoff; Thyra E de Jongh; Bruce A Averill
Journal:  J Biol Inorg Chem       Date:  2005-09-23       Impact factor: 3.358

5.  Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications.

Authors:  Brian Christensen; Mette S Nielsen; Kim F Haselmann; Torben E Petersen; Esben S Sørensen
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

Review 6.  Type I interferon and systemic lupus erythematosus.

Authors:  Keith B Elkon; Vivian V Stone
Journal:  J Interferon Cytokine Res       Date:  2011-08-22       Impact factor: 2.607

7.  Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity.

Authors:  Ekkehart Lausch; Andreas Janecke; Matthias Bros; Stefanie Trojandt; Yasemin Alanay; Corinne De Laet; Christian A Hübner; Peter Meinecke; Gen Nishimura; Mari Matsuo; Yoshiko Hirano; Sylvie Tenoutasse; Andrea Kiss; Rafael Fabiano Machado Rosa; Sharon L Unger; Raffaele Renella; Luisa Bonafé; Jürgen Spranger; Sheila Unger; Bernhard Zabel; Andrea Superti-Furga
Journal:  Nat Genet       Date:  2011-01-09       Impact factor: 38.330

8.  Modulation of bone resorption by phosphorylation state of bone sialoprotein.

Authors:  Paul Curtin; Kevin P McHugh; Hai-Yan Zhou; Rudolf Flückiger; Paul Goldhaber; Frank G Oppenheim; Erdjan Salih
Journal:  Biochemistry       Date:  2009-07-28       Impact factor: 3.162

Review 9.  Immunogenetics of systemic lupus erythematosus: A comprehensive review.

Authors:  Yogita Ghodke-Puranik; Timothy B Niewold
Journal:  J Autoimmun       Date:  2015-08-29       Impact factor: 7.094

10.  Induction and cellular expression of tartrate resistant acid phosphatase during dextran sodium sulphate induced colitis in rats.

Authors:  Pernilla Lång; Stefan Lange; Dick Delbro; Göran Andersson
Journal:  Histochem Cell Biol       Date:  2009-10-11       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.